Stay updated on Clinical Trial: Reboxetine in Narcolepsy & Cataplexy
Sign up to get notified when there's something new on the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page.

Latest updates to the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page
- Check3 days agoChange DetectedStudy locations were updated to include Stockbridge, GA and remove St. Petersburg, FL, and IPD data-sharing fields were added to indicate IPD sharing status.SummaryDifference0.8%

- Check10 days agoChange DetectedAdded recruitment status note No longer looking for participants and introduced user-guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) to aid visitors. Updated the Intervention/Treatment label formatting and included a Revision: v3.6.0 note, reflecting a content and documentation update.SummaryDifference0.4%

- Check18 days agoChange DetectedA revision label has been updated from v3.5.4 to v3.5.5 on the page, indicating a minor version update to the page or system hosting the study record. This change does not alter study content or user-facing data.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, signaling a deployment-level update to the site’s underlying tooling. No study text or visible content appears to have changed.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page revision identifier was updated from v3.5.2 to v3.5.3, indicating a minor version update to the page.SummaryDifference0.1%

- Check68 days agoChange DetectedFooter revision updated from v3.5.0 to v3.5.2. This appears to be a technical update and does not affect study details or primary page functionality.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Reboxetine in Narcolepsy & Cataplexy
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page.